HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 15,510
-200 (-1.27%)
At close: Feb 27, 2026
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 217.8 billion as of February 27, 2026. Its market cap has decreased by -40.12% in one year.
Market Cap
217.80B
Enterprise Value
208.14B
Revenue
36.10B
Ranking
n/a
PE Ratio
460.79
Stock Price
15,510.00
Market Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 217.80B, an increase of 158.42%. That is a compound annual growth rate of 9.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 217.80B | -3.30% |
| Dec 30, 2025 | 225.24B | -33.44% |
| Dec 30, 2024 | 338.42B | 58.45% |
| Dec 28, 2023 | 213.58B | 43.49% |
| Dec 29, 2022 | 148.85B | -21.48% |
| Dec 30, 2021 | 189.57B | -21.05% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chong Kun Dang Holdings | 251.83B |
| Samil Pharmaceutical Co.,Ltd | 247.33B |
| Daewon Pharmaceutical | 244.98B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| Samjin Pharmaceuticals | 231.43B |
| Jeil Pharmaceutical Co.,Ltd | 230.67B |
| JW Lifescience | 211.98B |
| AptaBio Therapeutics | 210.14B |